Extended-release physostigmine in Alzheimer disease: a multicenter, double-blind, 12-week study with dose enrichment. Physostigmine Study Group. (Q53339170)
Jump to navigation
Jump to search
scientific article published in February 2000
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Extended-release physostigmine in Alzheimer disease: a multicenter, double-blind, 12-week study with dose enrichment. Physostigmine Study Group. |
scientific article published in February 2000 |
Statements
Extended-release physostigmine in Alzheimer disease: a multicenter, double-blind, 12-week study with dose enrichment. Physostigmine Study Group. (English)
van Dyck CH
Newhouse P
Falk WE
Mattes JA
1 February 2000
57
2
157-164